// App-Quantinova.ai

2130 : Prognostic Importance Of Thrombocytopenia On Day 60 After Allogeneic Stem Cell Transplantation For Acute Leukemia

Researchers

Presenter

  • Eriko Ogusa

Principal Investigators

  • Wataru Yamamoto

  • Kenji Matsumoto

  • Yoshiaki Ishigatsubo

  • Heiwa Kanamori

Medical Centers

  • Department of Gynecology, Kanagawa Cancer Center, Kanagawa, Japan

  • Department of Thoracic Oncology, Kanagawa Cancer Center, Yokohama, Japan

  • Department of Internal Medicine and Clinical Immunology, Yokohama City University Graduate School of Medicine, Yokohama, Japan

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Acute lymphoblastic leukemia

  • Graft-versus-host disease

  • Acute myelocytic leukemia

  • Thrombocytopenia

  • Acute Leukemia

Biomarkers

  • Soluble Complement 5b-9

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved